NCT04970407View on ClinicalTrials.gov

A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 6, 2021

Primary Completion Date

March 16, 2022

Study Completion Date

June 8, 2022

Conditions
Healthy Participants
Interventions
BIOLOGICAL

Botulinum toxin type A

Intramuscular Injection, concentration 300 units (U)

BIOLOGICAL

Botulinum toxin type A

Intramuscular Injection, concentration 50 U

BIOLOGICAL

Botulinum toxin type A

Intramuscular Injection, concentration 50 U

Trial Locations (1)

Unknown

Mac Research Clinical research Unit, Manchester

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY

NCT04970407 - A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants | Biotech Hunter | Biotech Hunter